Citation

Bighelli I, Samara MT, Rodolico A, Hansen WP, Leucht S. Cochrane Database Syst. Rev. 2021; 2021(4).

Copyright

(Copyright © 2021, The Cochrane Collaboration, Publisher John Wiley and Sons)

DOI

10.1002/14651858.CD014384

PMID

unavailable

Abstract

OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity. Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Language: en

Keywords

human; age; gender; suicide; systematic review; quality of life; depression; aggression; schizophrenia; mortality; scoring system; race; length of stay; drug safety; drug fatality; clinical protocol; drug efficacy; olanzapine; disease exacerbation; patient satisfaction; schizoaffective psychosis; schizophreniform disorder; drug dose reduction; delusional disorder; Article; hospital readmission; Positive and Negative Syndrome Scale; randomized controlled trial (topic); body weight gain; clinical outcome; Scale for the Assessment of Negative Symptoms; global state scale